COVAXIN expected to be ready by June 2021, says Bharat Biotech

Bharat Biotech expects to have its coronavirus vaccine candidate COVAXIN ready by June 2021, said a top official of the company. The firm recently received approval for late-stage human trials of COVAXIN, which is being developed in collaboration with the ICMR. It plans to test over 20,000 volunteers across 12-14 states.